Marco C Miotto

9PUBLICATIONS
33CO-AUTHORS
Molecular targetsAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesStructure and dynamics of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 04, 2026
Structural basis for rosuvastatin-induced activation of skeletal muscle ryanodine receptor 1.

|Aug 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.

Alexander Chang, Halil Beqaj, Leah Sittenfeld

|Jun 13, 2025
Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders.

Marco C Miotto, Estefania Luna-Figueroa, Carl Tchagou

|Sep 15, 2024
Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders.

Marco C Miotto, Steven Reiken, Anetta Wronska

|Jun 25, 2024
Structural insights into the regulation of RyR1 by S100A1.

Gunnar Weninger, Marco C Miotto, Carl Tchagou

|Sep 27, 2023
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice.

Yang Liu, Steven Reiken, Haikel Dridi

Pageof 2

Frequent Collaborators

7 joint publications

Yang Liu

6 joint publications

Haikel Dridi

6 joint publications

Steven Reiken

4 joint publications

Anetta Wronska